Windlas Biotech Limited (NSE:WINDLAS)
India · Delayed Price · Currency is INR 813.10
-20.00 (-2.40%)
Jun 1, 2026, 3:30 PM IST
Windlas Biotech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 9,041 | 7,599 | 6,310 | 5,131 | 4,659 | |
Revenue Growth (YoY) | 18.98% | 20.43% | 22.97% | 10.12% | 8.96% |
Cost of Revenue | 5,572 | 4,748 | 4,004 | 3,296 | 3,079 |
Gross Profit | 3,469 | 2,851 | 2,305 | 1,835 | 1,581 |
Selling, General & Admin | 1,521 | 1,265 | 927.74 | 736.88 | 656.86 |
Other Operating Expenses | 900.2 | 640.8 | 595.94 | 495.85 | 399.53 |
Operating Expenses | 2,729 | 2,186 | 1,658 | 1,356 | 1,178 |
Operating Income | 739.99 | 664.94 | 647.28 | 478.7 | 402.76 |
Interest Expense | -48.26 | -43.82 | -11.05 | -7.88 | -14.17 |
Interest & Investment Income | - | 15.45 | 19.69 | 34.9 | 42.85 |
Currency Exchange Gain (Loss) | - | 4.88 | 3.23 | 3.82 | 4.77 |
Other Non Operating Income (Expenses) | 178.04 | 5.25 | 3.49 | 4.35 | 0.77 |
EBT Excluding Unusual Items | 869.77 | 646.7 | 662.64 | 513.89 | 436.98 |
Gain (Loss) on Sale of Investments | - | 150.79 | 108.21 | 47.82 | 18.57 |
Gain (Loss) on Sale of Assets | - | 0.09 | 0.06 | 8.76 | 0.1 |
Asset Writedown | - | - | - | -0.08 | - |
Pretax Income | 869.77 | 797.58 | 770.91 | 570.39 | 455.65 |
Income Tax Expense | 205.21 | 187.64 | 189.04 | 144.13 | 74.76 |
Earnings From Continuing Operations | 664.56 | 609.94 | 581.87 | 426.26 | 380.89 |
Net Income | 664.56 | 609.94 | 581.87 | 426.26 | 380.89 |
Net Income to Common | 664.56 | 609.94 | 581.87 | 426.26 | 380.89 |
Net Income Growth | 8.96% | 4.82% | 36.51% | 11.91% | 140.58% |
Shares Outstanding (Basic) | 21 | 21 | 21 | 22 | 20 |
Shares Outstanding (Diluted) | 21 | 21 | 21 | 22 | 20 |
Shares Change (YoY) | 0.98% | 1.22% | -3.53% | 5.56% | 12.58% |
EPS (Basic) | 31.60 | 29.19 | 27.97 | 19.70 | 18.58 |
EPS (Diluted) | 31.15 | 28.87 | 27.88 | 19.70 | 18.58 |
EPS Growth | 7.90% | 3.55% | 41.52% | 6.03% | 113.68% |
Free Cash Flow | 372.7 | 159.93 | 712.76 | -99.25 | -56.74 |
Free Cash Flow Per Share | 17.47 | 7.57 | 34.15 | -4.59 | -2.77 |
Dividend Per Share | 6.300 | 5.800 | 5.500 | 4.000 | 3.500 |
Dividend Growth | 8.62% | 5.46% | 37.50% | 14.29% | - |
Gross Margin | 38.37% | 37.52% | 36.54% | 35.77% | 33.92% |
Operating Margin | 8.19% | 8.75% | 10.26% | 9.33% | 8.64% |
Profit Margin | 7.35% | 8.03% | 9.22% | 8.31% | 8.18% |
Free Cash Flow Margin | 4.12% | 2.10% | 11.30% | -1.93% | -1.22% |
EBITDA | 1,047 | 909.63 | 762.1 | 586.88 | 515.48 |
EBITDA Margin | 11.58% | 11.97% | 12.08% | 11.44% | 11.06% |
D&A For EBITDA | 307.43 | 244.69 | 114.82 | 108.18 | 112.72 |
EBIT | 739.99 | 664.94 | 647.28 | 478.7 | 402.76 |
EBIT Margin | 8.19% | 8.75% | 10.26% | 9.33% | 8.64% |
Effective Tax Rate | 23.59% | 23.53% | 24.52% | 25.27% | 16.41% |
Revenue as Reported | 9,219 | 7,779 | 6,444 | 5,230 | 4,726 |
Advertising Expenses | - | 27.87 | 48.32 | 29.75 | 18.4 |